TotalSeq™-B0232 anti-mouse MAdCAM-1 Antibody, MAdCAM-1, MECA-367,BioLegend,120721

Additional reported applications (for the relevant formats) include:in vitroandin vivoblocking of lymphocyte adhesion andin vivoblocking of lymphocyte homing1-4,7, immunohistochemical staining1,5,6of acetone-fixed frozen sections, immunoprecipitation, and Western blotting1.

Host

Rat

Reactivity

Mouse

Application

PG -Quality tested

Platform ID

BAB502315768

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-B0232 anti-mouse MAdCAM-1 Antibody, MAdCAM-1, MECA-367
Cat. No.120721
HostRat
RRIDAB_2860645 (BioLegend Cat. No. 120721)
IsotypeRat IgG2a, κ
ReactivityMouse
ApplicationPG -Quality tested
ClonalityMonoclonal
Clone NumberMECA-367
Concentration0.5 mg/mL
TargetMAdCAM-1
ImmunogenEndothelial cells
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

MAdCAM-1 is a 58-66kD type I glycoprotein, also known as Mucosal addressin cell adhesion molecule-1. This mucosal vascular addressin is a member of the Ig superfamily found on fetus and neonatal endothelial cells. In adults, MAdCAM-1 is predominately expressed on high endothelial venule (HEV) of Peyer's patches, mesenteric lymph nodes and gut lamina propria. It is also expressed on vascular endothelium in mammary glands and pancreas. MAdCAM-1, through its interaction with integrin α4β7 or CD62L, is involved in lymphocyte tethering, rolling, and homing. It has been reported that immobilized MAdCAM-1 is able to co-stimulate T cell proliferation. The MECA-367 antibody blocks the interaction of MAdCAM-1 with its counter-receptor bothin vitroandin vivo.In vivoadministration of the mAb is able to reduce T-cell mediated inflammation in some gastrointestinal diseases.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.